These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 29285807)

  • 1. Doramectin in the treatment of generalized demodicosis.
    Cordero AM; Quek S; Mueller RS
    Vet Dermatol; 2018 Apr; 29(2):104-e41. PubMed ID: 29285807
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of canine generalized demodicosis using weekly injections of doramectin: 232 cases in the USA (2002-2012).
    Hutt JH; Prior IC; Shipstone MA
    Vet Dermatol; 2015 Oct; 26(5):345-9, e73. PubMed ID: 26190685
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Canine generalized demodicosis treated with varying doses of a 2.5% moxidectin+10% imidacloprid spot-on and oral ivermectin: parasiticidal effects and long-term treatment outcomes.
    Paterson TE; Halliwell RE; Fields PJ; Louw ML; Ball G; Louw J; Pinckney R
    Vet Parasitol; 2014 Oct; 205(3-4):687-96. PubMed ID: 25262617
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of canine-generalized demodicosis: a blind, randomized clinical trial comparing the efficacy of Advocate(Bayer Animal Health) with ivermectin.
    Paterson TE; Halliwell RE; Fields PJ; Louw ML; Louw JP; Ball GS; Pinckney RD; McKibben JS
    Vet Dermatol; 2009 Oct; 20(5-6):447-55. PubMed ID: 20178483
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A proposed new therapeutic protocol for the treatment of canine mange with ivermectin.
    Mueller RS; Bettenay SV
    J Am Anim Hosp Assoc; 1999; 35(1):77-80. PubMed ID: 9934933
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of orally administered fluralaner (Bravecto™) or topically applied imidacloprid/moxidectin (Advocate®) against generalized demodicosis in dogs.
    Fourie JJ; Liebenberg JE; Horak IG; Taenzler J; Heckeroth AR; Frénais R
    Parasit Vectors; 2015 Mar; 8():187. PubMed ID: 25881320
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ivermectin for treatment of generalized demodicosis in dogs.
    Ristic Z; Medleau L; Paradis M; White-Weithers NE
    J Am Vet Med Assoc; 1995 Nov; 207(10):1308-10. PubMed ID: 7591924
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of the therapeutic and protective efficacy of doramectin against psoroptic scabies in cattle.
    Clymer BC; Janes TH; McKenzie ME
    Vet Parasitol; 1997 Sep; 72(1):79-89. PubMed ID: 9403979
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of canine generalized demodicosis with a 'spot-on' formulation containing 10% moxidectin and 2.5% imidacloprid (Advocate, Bayer Healthcare).
    Mueller RS; Meyer D; Bensignor E; Sauter-Louis C
    Vet Dermatol; 2009 Oct; 20(5-6):441-6. PubMed ID: 20178482
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oral selamectin in the treatment of canine generalised demodicosis.
    Schnabl B; Bettenay S; Glos N; Linek M; Loewenstein C; Mueller RS
    Vet Rec; 2010 Jun; 166(23):710-4. PubMed ID: 20525946
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of weekly oral doramectin treatment in canine demodicosis.
    Murayama N; Shibata K; Nagata M
    Vet Rec; 2010 Jul; 167(2):63-4. PubMed ID: 20622206
    [No Abstract]   [Full Text] [Related]  

  • 12. Treatment of canine generalized demodicosis associated with hyperadrenocorticism with spot-on moxidectin and imidacloprid.
    Huang HP; Lien YH
    Acta Vet Scand; 2013 May; 55(1):40. PubMed ID: 23663380
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Monthly application of 10 per cent moxidectin and 2.5 per cent imidacloprid spot-on to prevent relapses in generalised demodicosis: a pilot study.
    Colombo S; Leone F; Vercelli A; Cornegliani L
    Vet Rec; 2012 Sep; 171(11):272. PubMed ID: 22791522
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Systemic therapy for generalized canine demodicosis.
    Charach MG
    Can Vet J; 1995 Nov; 36(11):721. PubMed ID: 8590432
    [No Abstract]   [Full Text] [Related]  

  • 15. Evaluation of the efficacy and safety of imidacloprid 10% plus moxidectin 2.5% spot-on in the treatment of generalized demodicosis in dogs: results of a European field study.
    Heine J; Krieger K; Dumont P; Hellmann K
    Parasitol Res; 2005 Oct; 97 Suppl 1():S89-S96. PubMed ID: 16228281
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Spectrum of activity of doramectin against cattle mites and lice.
    Logan NB; Weatherley AJ; Phillips FE; Wilkins CP; Shanks DJ
    Vet Parasitol; 1993 Jul; 49(1):67-73. PubMed ID: 8236741
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of the efficacy of an imidacloprid 10%/moxidectin 2.5% spot-on against Sarcoptes scabieivar canison dogs.
    Fourie LJ; Du Rand C; Heine J
    Parasitol Res; 2003 Jul; 90 Suppl 3():S135-6. PubMed ID: 12928880
    [No Abstract]   [Full Text] [Related]  

  • 18. Efficacy of oral fluralaner for the treatment of canine generalized demodicosis: a molecular-level confirmation.
    Djuric M; Milcic Matic N; Davitkov D; Glavinic U; Davitkov D; Vejnovic B; Stanimirovic Z
    Parasit Vectors; 2019 May; 12(1):270. PubMed ID: 31138280
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A trial of doramectin injection and ivermectin spot-on for treatment of rabbits artificially infested with the ear mite "Psoroptes cuniculi".
    Elhawary NM; Sorour SSGH; El-Abasy MA; Bazh EK; Sultan K
    Pol J Vet Sci; 2017 Sep; 20(3):521-525. PubMed ID: 29166286
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment protocols for demodicosis: an evidence-based review.
    Mueller RS
    Vet Dermatol; 2004 Apr; 15(2):75-89. PubMed ID: 15030556
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.